Korean J Urol.
1989 Aug;30(4):514-517.
Effects of Prazosin in Patients with Chronic Nonbacterial Prostatitis
- Affiliations
-
- 1Department of Urology, School of Meidicine, Hallym University, Seoul, Korea.
Abstract
-
Prazosin, a selective alpha-1-adrenoreceptor blocker, was used in a double-blind fashion to evaluate its efficacy in 20 men with chronic nonbacterial prostatitis who have no improvement with conventional treatments for 4 weeks. When the drug was compared to placebo therapy, obstructive and irritative voiding sympment with conventional treatments for 4 weeks. When the drug was compared to placebo therapy, obstructive and irritative voiding symptoms were improved (p<0.05). No side effects were noted except one who had indigestion.